Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,343,000 | -2,822,000 | -1,996,000 | -1,796,000 | -971,000 |
| Depreciation Amortization | 48,000 | 148,000 | 94,000 | 59,000 | 20,000 |
| Accounts receivable | 114,000 | 156,000 | -703,000 | 310,000 | 280,000 |
| Accounts payable and accrued liabilities | -120,000 | -92,000 | -114,000 | -203,000 | -156,000 |
| Other Working Capital | 553,000 | 233,000 | -1,326,000 | -508,000 | -211,000 |
| Other Operating Activity | 118,000 | 504,000 | 1,242,000 | 182,000 | 1,000 |
| Operating Cash Flow | $-630,000 | $-1,873,000 | $-2,803,000 | $-1,956,000 | $-1,037,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62,000 | -192,000 | -153,000 | -120,000 | -117,000 |
| Purchase Of Investment | -1,348,000 | -5,768,000 | -4,221,000 | -3,059,000 | -1,764,000 |
| Sale Of Investment | 1,334,000 | 7,916,000 | 6,378,000 | 4,483,000 | 2,621,000 |
| Purchase Sale Intangibles | 0 | -10,000 | -10,000 | -10,000 | -10,000 |
| Other Investing Activity | 0 | -10,000 | -10,000 | -10,000 | -10,000 |
| Investing Cash Flow | $-76,000 | $1,946,000 | $1,994,000 | $1,294,000 | $730,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 600,000 | N/A | N/A | N/A |
| Common Stock Issued | 19,000 | 35,000 | 19,000 | 17,000 | 3,000 |
| Other Financing Activity | -2,000 | -42,000 | -7,000 | -4,000 | 1,000 |
| Financing Cash Flow | $17,000 | $593,000 | $12,000 | $13,000 | $4,000 |
| Exchange Rate Effect | 1,000 | 2,000 | 2,000 | 1,000 | 0 |
| Beginning Cash Position | 2,597,000 | 1,929,000 | 1,929,000 | 1,929,000 | 1,929,000 |
| End Cash Position | 1,909,000 | 2,597,000 | 1,134,000 | 1,281,000 | 1,626,000 |
| Net Cash Flow | $-688,000 | $668,000 | $-795,000 | $-648,000 | $-303,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -630,000 | -1,873,000 | -2,803,000 | -1,956,000 | -1,037,000 |
| Capital Expenditure | -62,000 | -192,000 | -153,000 | -120,000 | -117,000 |
| Free Cash Flow | -692,000 | -2,065,000 | -2,956,000 | -2,076,000 | -1,154,000 |